Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
ABUS holding history
Arbutus Biopharma Corp in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABUS overviewAll 13F holders of ABUSFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −107,107−100.0% | Sold out | Holders |
| Q1 2023 | 107,107 | $324.5K | <0.1% | +877+0.8% | Added | Holders |
| Q4 2022 | 106,230 | $247.5K | <0.1% | +24,352+29.7% | Added | Holders |
| Q3 2022 | 81,878 | $156.0K | <0.1% | −6,346−7.2% | Reduced | Holders |
| Q2 2022 | 88,224 | $239.0K | <0.1% | −64,538−42.2% | Reduced | Holders |
| Q1 2022 | 152,762 | $455.0K | <0.1% | −3,784−2.4% | Reduced | Holders |
| Q4 2021 | 156,546 | $609.0K | <0.1% | +156,546 | New | Holders |